Latest News about AKBA
Recent news which mentions AKBA
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
From Benzinga
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
October 11, 2022
From Benzinga
From Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
September 27, 2022
From Benzinga
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
September 22, 2022
From Benzinga
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
September 22, 2022
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study
August 05, 2022
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
U.S Stocks Turn Lower; Dow Tumbles Over 100 Points
July 01, 2022
From Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
July 01, 2022
From Benzinga
Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today?
July 01, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Akebia Therapeutics And 20 Stocks Moving Premarket
July 01, 2022
From Benzinga
From Benzinga
From Benzinga
Aspen Aerogels And 28 Stocks Moving Premarket
June 30, 2022
From Benzinga
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.